Pricing Log in Create free account
Friday 6 November 2026 Export RDNT’s income statement to Excel — free account

RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue
+25.0%
EPS
−47.4%
Free cash flow
−43.2%
Total debt
+21.2%

Quarter to June 2026, against a year earlier

77.28 0.73 −0.94%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
1,050×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

RadNet, Inc. (RDNT) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Oct 26, 2026 1.01 Entry into a material definitive agreement; 3.02 Unregistered sales of equity securities; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 14, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 37 added · 8 removed · 47 modified
P2I1A: no changes
8-K Aug 9, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 10, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 3, 2026 5.07 Submission of matters to a vote of security holders
8-K Jun 3, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 10, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 20 added · 2 removed · 43 modified
1A: 33 modified
7: 40 added · 39 removed · 27 modified
8-K Mar 2, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 30, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jan 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Dec 4, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 9, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 21, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 10, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 11, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
10-Q Sep 30, 2024
8-K Nov 10, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Aug 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K May 8, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 29, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 8, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.